We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

147 hedge funds and large institutions have $1.11B invested in AUXILIUM PHARAMCEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,948% more call options, than puts

Call options by funds: $191M | Put options by funds: $9.33M

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

12% more capital invested

Capital invested by funds: $987M → $1.11B (+$120M)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

2% less funds holding

Funds holding: 150 → 147 (-3)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
147
Holders Change
-3
Holders Change %
-2%
% of All Funds
4.27%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
22
Increased
61
Reduced
49
Closed
25
Calls
$191M
Puts
$9.33M
Net Calls
+$182M
Net Calls Change
+$49.4M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$30.6M
2
TCP
TAMRO Capital Partners
Virginia
+$17.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.7M
4
TCM
Tamarack Capital Management
California
+$13.7M
5
PHS
PFM Health Sciences
California
+$11.9M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$21.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$20.6M
3
SCA
SAC Capital Advisors
Connecticut
-$13.4M
4
Invesco
Invesco
Georgia
-$11M
5
MHP
Manatuck Hill Partners
Connecticut
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Caisse de Depot et Placement du Quebec (CDPQ)
151
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
– -$6.53M -358,000 Closed
PCM
152
Proxima Capital Management
New York
– -$6.47M -355,722 Closed
PC
153
PointState Capital
New York
– -$5M -275,000 Closed
PCM
154
Penn Capital Management
Pennsylvania
– -$3.2M -175,671 Closed
Bessemer Group
155
Bessemer Group
New Jersey
– -$1.82M -100,000 Closed
JGC
156
J. Goldman & Co
New York
– -$1.7M -90,000 Closed
FWIA
157
Fort Washington Investment Advisors
Ohio
– -$1.56M -85,610 Closed
Fuller & Thaler Asset Management
158
Fuller & Thaler Asset Management
California
– -$1.55M -85,000 Closed
VAM
159
Visium Asset Management
New York
– -$1.37M -75,000 Closed
EA
160
Emerald Advisers
Pennsylvania
– -$1.35M -74,180 Closed
B
161
Barings
North Carolina
– -$423K -23,198 Closed
SFP
162
Santa Fe Partners
New Mexico
– -$374K -20,596 Closed
B
163
Baird
Wisconsin
– -$310K -17,012 Closed
WMSA
164
Weiss Multi-Strategy Advisers
New York
– -$273K -15,000 Closed
HCM
165
Highbridge Capital Management
New York
– -$270K -14,883 Closed
PCM
166
Prelude Capital Management
New York
– -$265K -14,562 Closed
SG Americas Securities
167
SG Americas Securities
New York
– -$208K -11,390 Closed
SO
168
STRS Ohio
Ohio
– -$153K -8,400 Closed
CCMH
169
Cornerstone Capital Management Holdings
New York
– -$152K -8,361 Closed
SSG
170
Summit Securities Group
New York
– -$104K -5,717 Closed
CFA
171
Carroll Financial Associates
North Carolina
– -$49K -2,700 Closed
MCM
172
Manchester Capital Management
Vermont
– -$6K -335 Closed
3 4 5 6
7

AUXL Hedge Fund Activity: Q4 2013 in Review

147 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2013, worth a combined $1.11B — up 12% from $987M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of AUXL and 22 opened new positions — a net loss of 3 holders — while 49 trimmed existing stakes and 61 added.

The largest buyer was Deerfield Management, adding an estimated $30.6M. The largest seller was Artal Group, cutting an estimated $21.4M.

  • 147 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2013, down from 150 in Q3 2013.
  • Funds reported $1.11B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2013, up 12% quarter-over-quarter.
  • 22 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2013 and 25 closed out, a net change of -3 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2013 was Deerfield Management, an estimated $30.6M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2013 was Artal Group, an estimated $21.4M sold.

Based on aggregated 13F filings for Q4 2013.